Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:6712'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.91 Med: 2.82 Max: 3.8
Current: 2.27
During the past 10 years, Ever Supreme Bio Technology Co's highest Yield on Cost was 3.80. The lowest was 0.91. And the median was 2.82.
ROCO:6712's 5-Year Yield-on-Cost % is ranked better than 58.39% of 149
companies
in the Biotechnology industry
Industry Median: 1.64
vs ROCO:6712: 2.27
Ever Supreme Bio Technology Co (ROCO:6712) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Ever Supreme Bio Technology Co 5-Year Yield-on-Cost % Related Terms
ROCO:6712 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ever Supreme Bio Technology Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost % falls into.
Ever Supreme Bio Technology Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Ever Supreme Bio Technology Co (ROCO:6712) has a 5-Year Yield-on-Cost % of 2.27 as of Aug. 18, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ever Supreme Bio Technology Co and its competitors. This is 20% below median its historical median of 2.82. Over the past decade, Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost % has ranged from 0.91 to 3.80. According to the industry distribution chart, Ever Supreme Bio Technology Co ranks #62 out of 149 companies in the Biotechnology industry, placing it in the top 41.6%.
Is Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost % too high?
Ever Supreme Bio Technology Co's current 5-Year Yield-on-Cost % of 2.27 is 20% below median its 10-year median of 2.82. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 3.80. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.64. Ever Supreme Bio Technology Co's value of 2.27 is 38.4% above this industry median. Based on the distribution chart, Ever Supreme Bio Technology Co ranks #62 out of 149 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ever Supreme Bio Technology Co ranks #62 out of 149 companies for 5-Year Yield-on-Cost %. This puts Ever Supreme Bio Technology Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 1.64. Ever Supreme Bio Technology Co's value of 2.27 is 38.4% above this benchmark. Historically, Ever Supreme Bio Technology Co's own 5-Year Yield-on-Cost % has ranged from 0.91 to 3.80 over the past decade. While the company's 10-year median is 2.82 vs. the industry median of 1.64, Ever Supreme Bio Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.64, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ever Supreme Bio Technology Co's current 5-Year Yield-on-Cost % of 2.27 is 38.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ever Supreme Bio Technology Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ever Supreme Bio Technology Co's current 5-Year Yield-on-Cost % is 2.27, which is 20% below median its own 10-year median of 2.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$192.15, compared to a current price of NT$148.50 — trading 22.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.27, which is 20% below median its 10-year median of 2.82 and 38.4% above the Biotechnology industry median of 1.64. Ever Supreme Bio Technology Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current 5-Year Yield-on-Cost % is 2.27 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued.
The current stock price of NT$148.50 is trading 22.7% below its estimated GF Value™ of NT$192.15.
GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:6712:
5-Year Yield-on-Cost %: 2.27 (20% below median its 10-year median of 2.82)
GF Value™: NT$192.15 vs. price of NT$148.50 (22.7% below fair value)
Industry Position: 38.4% above the Biotechnology median (#62 of 149)
No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
91GF Score
Get the complete analysis for ROCO:6712
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6712 has been successfully added to your 
